Nephron Pharmaceuticals
West Columbia, South Carolina, United States · Biotechnology, Health Care, Pharmaceutical · 854 employees
Nephron Pharmaceuticals, founded in 1997 by Lou and Bill Kennedy, is a leading provider of generic respiratory and 503B outsourcing medications. The Company specializes in sterile dose medications and compounded solutions, developing, testing, producing, and shipping high volumes of sterile drugs. Nephron serves wholesalers, retailers, and hospitals nationwide, addressing drug shortages and streng
Funding history
- Debt Financing — $350.0M — Jan 2025
- Funding Round — $350.0M — Sep 2023
Recent signals
- Jan 10, 2025: Raised $350.0M in Debt Financing
- Sep 15, 2023: Raised $350.0M in Funding Round
- Aug 17, 2023: Nephron Announces Julie Rameas as Chief Procurement Officer
- Jun 08, 2023: Nephron Announces New President of 503B Outsourcing Facility
See plans & pricing → Track Nephron Pharmaceuticals’s funding, hiring, and signals — with verified contacts — on Fundz.